<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">genort</journal-id><journal-title-group><journal-title xml:lang="ru">Гений ортопедии</journal-title><trans-title-group xml:lang="en"><trans-title>Genij Ortopedii</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1028-4427</issn><issn pub-type="epub">2542-131X</issn><publisher><publisher-name>ЦЕНТР ИЛИЗАРОВА</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18019/1028-4427-2023-29-5-557-564</article-id><article-id custom-type="edn" pub-id-type="custom">ICPSYS</article-id><article-id custom-type="elpub" pub-id-type="custom">genort-2871</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Случай из практики</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Case report</subject></subj-group></article-categories><title-group><article-title>Mycobacterium abscessus как возбудитель перипротезной инфекции</article-title><trans-title-group xml:lang="en"><trans-title>Mycobacterium abscessus as a causative agent of periprosthetic infection</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6284-7133</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Касимова</surname><given-names>А. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Kasimova</surname><given-names>A. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алина Рашидовна Касимова – кандидат медицинских наук, клинический фармаколог, доцент</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Alina R. Kasimova – Candidate of Medical Sciences, Clinical Pharmacologist, Associate Professor</p><p>St. Petersburg</p></bio><email xlink:type="simple">kasi-alina@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8573-1096</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кочиш</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kochish</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Андрей Александрович Кочиш – кандидат медицинских наук, врач травматолог-ортопед</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Andrey A. Kochish – Candidate of Medical Sciences, traumatologist-orthopedist</p><p>St. Petersburg</p></bio><email xlink:type="simple">aakochish@rniito.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2326-7413</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гордина</surname><given-names>Е. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Gordina</surname><given-names>E. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Екатерина Михайловна Гордина – кандидат медицинских наук, старший научный сотрудник</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Ekaterina M. Gordina – Candidate of Medical Sciences, Senior Researcher</p><p>St. Petersburg</p></bio><email xlink:type="simple">emgordina@win.rniito.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5087-6081</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Артюх</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Artyukh</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Василий Алексеевич Артюх – доктор медицинских наук, заведующий отделением</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Vasily A. Artyukh – Doctor of Medical Sciences, Head of Department</p><p>St. Petersburg</p></bio><email xlink:type="simple">artyukhva@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3307-4674</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рукина</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Rukina</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Анна Николаевна Рукина – заведующая лабораторией, младший научный сотрудник</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Anna N. Rukina – head of the laboratory, junior researcher</p></bio><email xlink:type="simple">anrukina@rniito.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2083-2424</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Божкова</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bozhkova</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Светлана Анатольевна Божкова – доктор медицинских наук, доцент, руководитель научного отделения, заведующая отделением</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Svetlana A. Bozhkova– Doctor of Medical Sciences, Associate Professor, Head of the Scientific Department, Head of the Department</p><p>St. Petersburg</p></bio><email xlink:type="simple">clinpharm-rniito@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр травматологии и ортопедии имени Р.Р. Вредена; Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Vreden National Medical Research Center of Traumatology and Orthopedics;  Pavlov First Saint Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр травматологии и ортопедии имени Р.Р. Вредена</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Vreden National Medical Research Center of Traumatology and Orthopedics</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>28</day><month>10</month><year>2023</year></pub-date><volume>29</volume><issue>5</issue><fpage>557</fpage><lpage>564</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Касимова А.Р., Кочиш А.А., Гордина Е.М., Артюх В.А., Рукина А.Н., Божкова С.А., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Касимова А.Р., Кочиш А.А., Гордина Е.М., Артюх В.А., Рукина А.Н., Божкова С.А.</copyright-holder><copyright-holder xml:lang="en">Kasimova A.R., Kochish A.A., Gordina E.M., Artyukh V.A., Rukina A.N., Bozhkova S.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ilizarov-journal.com/jour/article/view/2871">https://www.ilizarov-journal.com/jour/article/view/2871</self-uri><abstract><sec><title>Введение</title><p>Введение. Вид Mycobacterium abscessus относится к группе нетуберкулезных микобактерий, ответственных за хронические инфекции у лиц с ослабленным иммунитетом. M. abscessus способны колонизировать искусственные поверхности, в том числе медицинские и хирургические инструменты/устройства. В связи с низкой частотой встречаемости M. abscessus как возбудителя ортопедической инфекции он представляет несомненный интерес для практикующих врачей. Данный инфекционный агент является редким возбудителем, в отношении которого отсутствует отработанный лечебный алгоритм.</p></sec><sec><title>Цель</title><p>Цель. Представить способ достижения успешного результата лечения пациента с перипротезной инфекцией, вызванной M. abscessus.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Из историй болезни и выписных документов известно, что пациентке Х. по месту жительства выполнено тотальное эндопротезирование тазобедренного сустава. В раннем послеоперационном периоде манифестировали признаки острой инфекции послеоперационной раны.</p></sec><sec><title>Результаты</title><p>Результаты. Спустя три месяца пациентка госпитализирована в профильное учреждение с диагнозом хроническая глубокая перипротезная инфекция. При дообследовании установлена этиология процесса. Пациентке в две госпитализации последовательно выполнены 4 санирующие операции (в том числе мышечная пластика и установка антимикробного спейсера) и проводилась массивная парентеральная антибактериальная терапия в течение 8 месяцев, в том числе на амбулаторном этапе, с применением минимум 3‑х антибактериальных средств. Спустя 4 года пациентка не предъявляет жалоб со стороны очага инфекционного процесса. Послеоперационный рубец 45 см без особенностей. Оставшееся укорочение правой нижней конечности 3 см компенсируется ортопедической обувью.</p></sec><sec><title>Обсуждение</title><p>Обсуждение. Лечение инфекции, вызванной M. abscessus, является сложной задачей вследствие природной устойчивости возбудителя к широкому спектру антибактериальных лекарственных средств. В литературе описаны единичные случаи ортопедической инфекции, вызванной данным патогеном. Все авторы сходятся в том, что залогом успешного лечения является комбинация радикальной хирургической санации и антибактериальной терапии с применением минимум трех антимикробных препаратов.</p></sec><sec><title>Заключение</title><p>Заключение. Длительная агрессивная антибиотикотерапия в комбинации с этапным хирургическим лечением позволила добиться успеха при лечении пациента с перипротезной инфекцией, вызванной Mycobacterium abscessus, после первичного эндопротезирования тазобедренного сустава.</p></sec></abstract><trans-abstract xml:lang="en"><p>Introduction Mycobacterium abscessus species belongs to the group of non-tuberculosis mycobacteria responsible for chronic infections in people with weakened immunity. M. abscessus exist in various ecological niches and are able to colonize artificial surfaces, including medical and surgical instruments/ devices. Due tothe low incidence of M. abscessus as a causative agent of orthopedic infection, a rare clinical case of periprosthetic infection caused by M.abscessus would interest practitioners.</p><p>The aim is to present a clinical case of periprosthetic infection caused by M. abscessus.</p><p>Materials and methods From the medical records and discharge documents, it was known that female patient X. underwent total hip replacement at her residence hospital. Signs of acute infection of the postoperative wound appeared in the early postoperative period.</p><p>Results Three months later, the patient was hospitalized in a specialized institution with a diagnosis of chronic deep periprosthetic infection. During the examination, the mycobacterial etiology of the process was established. During two hospitalizations, the patient underwent 4 consecutive revision surgeries (including muscle plastic surgery and installation of an antimicrobial spacer) and massive parenteral antibiotic therapy for 8 months, including at the outpatient stage, using at least 3 antibacterial agents. After 4 years, the patient does not complain of the infectious process. Postoperative scar is 45 cm. The residual shortening of the right lower limb of 3 cm was compensated by orthopedic shoes.</p><p>Discussion Treatment of infection caused by M. abscessus is challenging due to the natural resistance of the pathogen to a wide range of antibacterial drugs. The literature describes separate cases of orthopedic infections caused by this pathogen. All authors agree that the key to successful treatment is a combination of radical surgical debridement and antibacterial therapy using at least three antimicrobial drugs.</p><p>Conclusion A rare clinical case of periprosthetic infection caused by Mycobacterium abscessus after primary hip replacement is presented. This infectious agent is a rare pathogen, for which there is no proven therapeutic algorithm. Long-term aggressive antibiotic therapy in combination with stage-by-stage surgical treatment was successful.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ортопедическая инфекция</kwd><kwd>перипротезная инфекция</kwd><kwd>нетуберкулезные микобактерии</kwd><kwd>Mycobacterium abscessus</kwd><kwd>антибактериальная терапия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>orthopedic infection</kwd><kwd>periprosthetic infection</kwd><kwd>non-tuberculosis mycobacteria</kwd><kwd>Mycobacterium abscessus</kwd><kwd>antibacterial therapy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Abdelaal HFM, Chan ED, Young L, et al. Mycobacterium abscessus: It's Complex. Microorganisms. 2022;10(7):1454. doi: 10.3390/ microorganisms10071454</mixed-citation><mixed-citation xml:lang="en">Abdelaal HFM, Chan ED, Young L, et al. Mycobacterium abscessus: It's Complex. Microorganisms. 2022;10(7):1454. doi: 10.3390/ microorganisms10071454</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrell KC, Johansen MD, Triccas JA, Counoupas C. Virulence Mechanisms of Mycobacterium abscessus: Current Knowledge and Implications for Vaccine Design. Front Microbiol. 2022;13:842017. doi: 10.3389/fmicb.2022.842017</mixed-citation><mixed-citation xml:lang="en">Ferrell KC, Johansen MD, Triccas JA, Counoupas C. Virulence Mechanisms of Mycobacterium abscessus: Current Knowledge and Implications for Vaccine Design. Front Microbiol. 2022;13:842017. doi: 10.3389/fmicb.2022.842017</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Nengue L, Diaz MAA, Sherman CE, et al. Mycobacterium abscessus Prosthetic Joint Infections of the Knee. J Bone Jt Infect. 2019;4(5):223-226. doi: 10.7150/jbji.36286</mixed-citation><mixed-citation xml:lang="en">Nengue L, Diaz MAA, Sherman CE, et al. Mycobacterium abscessus Prosthetic Joint Infections of the Knee. J Bone Jt Infect. 2019;4(5):223-226. doi: 10.7150/jbji.36286</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Rampacci E, Stefanetti V, Passamonti F, Henao-Tamayo M. Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research. Pathogens. 2020 6;9(8):641. doi: 10.3390/pathogens9080641</mixed-citation><mixed-citation xml:lang="en">Rampacci E, Stefanetti V, Passamonti F, Henao-Tamayo M. Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research. Pathogens. 2020 6;9(8):641. doi: 10.3390/pathogens9080641</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Vietor FI, Nelson TB. Difficulty in diagnosis and management of musculoskeletal nontuberculous mycobacterial infections. IDCases. 2022;29:e01527. doi: 10.1016/j.idcr.2022.e01527</mixed-citation><mixed-citation xml:lang="en">Vietor FI, Nelson TB. Difficulty in diagnosis and management of musculoskeletal nontuberculous mycobacterial infections. IDCases. 2022;29:e01527. doi: 10.1016/j.idcr.2022.e01527</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Fukui S, Sekiya N, Takizawa Y, et al. Disseminated Mycobacterium abscessus Infection Following Septic Arthritis: A Case Report and Review of the Literature. Medicine (Baltimore). 2015;94(21):e861. doi: 10.1097/MD.0000000000000861</mixed-citation><mixed-citation xml:lang="en">Fukui S, Sekiya N, Takizawa Y, et al. Disseminated Mycobacterium abscessus Infection Following Septic Arthritis: A Case Report and Review of the Literature. Medicine (Baltimore). 2015;94(21):e861. doi: 10.1097/MD.0000000000000861</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Meir M, Barkan D. Alternative and Experimental Therapies of Mycobacterium abscessus Infections. Int J Mol Sci. 2020;21(18):6793. doi: 10.3390/ ijms21186793</mixed-citation><mixed-citation xml:lang="en">Meir M, Barkan D. Alternative and Experimental Therapies of Mycobacterium abscessus Infections. Int J Mol Sci. 2020;21(18):6793. doi: 10.3390/ ijms21186793</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Malhotra R, Bala K, Gautam D, et al. Mycobacterium abscessus Periprosthetic joint infection following bilateral Total Knee arthroplasty. IDCases. 2019;17:e00542. doi: 10.1016/j.idcr.2019.e00542</mixed-citation><mixed-citation xml:lang="en">Malhotra R, Bala K, Gautam D, et al. Mycobacterium abscessus Periprosthetic joint infection following bilateral Total Knee arthroplasty. IDCases. 2019;17:e00542. doi: 10.1016/j.idcr.2019.e00542</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Rahi MS, Reyes SP, Parekh J, et al. Disseminated Mycobacterium abscessus infection and native valve endocarditis. Respir Med Case Rep. 2021;32:101331. doi: 10.1016/j.rmcr.2020.101331</mixed-citation><mixed-citation xml:lang="en">Rahi MS, Reyes SP, Parekh J, et al. Disseminated Mycobacterium abscessus infection and native valve endocarditis. Respir Med Case Rep. 2021;32:101331. doi: 10.1016/j.rmcr.2020.101331</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Jung SY, Kim BG, Kwon D, et al. An outbreak of joint and cutaneous infections caused by non-tuberculous mycobacteria after corticosteroid injection. Int J Infect Dis. 2015;36:62-9. doi: 10.1016/j.ijid.2015.05.018</mixed-citation><mixed-citation xml:lang="en">Jung SY, Kim BG, Kwon D, et al. An outbreak of joint and cutaneous infections caused by non-tuberculous mycobacteria after corticosteroid injection. Int J Infect Dis. 2015;36:62-9. doi: 10.1016/j.ijid.2015.05.018</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wong KP, Tang ZH, Tan GM. Mycobacterium fortuitum and Mycobacterium abscessus infections in the foot and ankle in two immunocompetent patients. Biomedicine (Taipei). 2020;10(4):52-56. doi: 10.37796/2211-8039.1021</mixed-citation><mixed-citation xml:lang="en">Wong KP, Tang ZH, Tan GM. Mycobacterium fortuitum and Mycobacterium abscessus infections in the foot and ankle in two immunocompetent patients. Biomedicine (Taipei). 2020;10(4):52-56. doi: 10.37796/2211-8039.1021</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kadota N, Shinohara T, Hino H, et al. Mycobacterium abscessus ssp. abscessus infection progressing to empyema from vertebral osteomyelitis in an immunocompetent patient without pulmonary disease: a case report. BMC Pulm Med. 2019;19(1):100. doi: 10.1186/s12890-019-0860-4</mixed-citation><mixed-citation xml:lang="en">Kadota N, Shinohara T, Hino H, et al. Mycobacterium abscessus ssp. abscessus infection progressing to empyema from vertebral osteomyelitis in an immunocompetent patient without pulmonary disease: a case report. BMC Pulm Med. 2019;19(1):100. doi: 10.1186/s12890-019-0860-4</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Farid F, Nakamae T, Kamei N, et al. Vertebral osteomyelitis due to Mycobacterium abscessus subsp. massiliense with paravertebral abscess: A case report and review. J Infect Chemother. 2023:S1341-321X(23)00134-4. doi: 10.1016/j.jiac.2023.05.020</mixed-citation><mixed-citation xml:lang="en">Farid F, Nakamae T, Kamei N, et al. Vertebral osteomyelitis due to Mycobacterium abscessus subsp. massiliense with paravertebral abscess: A case report and review. J Infect Chemother. 2023:S1341-321X(23)00134-4. doi: 10.1016/j.jiac.2023.05.020</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Omori K, Kitagawa H, Tadera K, et al. Vertebral osteomyelitis caused by Mycobacteroides abscessus subsp. abscessus resulting in spinal cord injury due to vertebral body fractures. J Infect Chemother. 2022;28(2):290-294. doi: 10.1016/j.jiac.2021.09.013</mixed-citation><mixed-citation xml:lang="en">Omori K, Kitagawa H, Tadera K, et al. Vertebral osteomyelitis caused by Mycobacteroides abscessus subsp. abscessus resulting in spinal cord injury due to vertebral body fractures. J Infect Chemother. 2022;28(2):290-294. doi: 10.1016/j.jiac.2021.09.013</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Tomori Y, Mochizuki T, Ohno H, et al. Purulent Flexor Tendon Rupture of the Hand due to Mycobacterium abscessus Infection: A Case Report and Review of the Literature. J Nippon Med Sch. 2022;89(3):347-354. doi: 10.1272/jnms.JNMS.2022_89-110</mixed-citation><mixed-citation xml:lang="en">Tomori Y, Mochizuki T, Ohno H, et al. Purulent Flexor Tendon Rupture of the Hand due to Mycobacterium abscessus Infection: A Case Report and Review of the Literature. J Nippon Med Sch. 2022;89(3):347-354. doi: 10.1272/jnms.JNMS.2022_89-110</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lee BI, Jang BW, Choi HS, et al. Arthroscopic treatment of Mycobacterium massiliense septic arthritis outbreak after intra-articular injection: A case-series report and literature review. Medicine (Baltimore). 2021;100(5):e23839. doi: 10.1097/MD.0000000000023839</mixed-citation><mixed-citation xml:lang="en">Lee BI, Jang BW, Choi HS, et al. Arthroscopic treatment of Mycobacterium massiliense septic arthritis outbreak after intra-articular injection: A case-series report and literature review. Medicine (Baltimore). 2021;100(5):e23839. doi: 10.1097/MD.0000000000023839</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kaushik A, Ammerman NC, Lee J, et al. In Vitro Activity of the New β-Lactamase Inhibitors Relebactam and Vaborbactam in Combination with β-Lactams against Mycobacterium abscessus Complex Clinical Isolates. Antimicrob Agents Chemother. 2019;63(3):e02623-18. doi: 10.1128/ AAC.02623-18</mixed-citation><mixed-citation xml:lang="en">Kaushik A, Ammerman NC, Lee J, et al. In Vitro Activity of the New β-Lactamase Inhibitors Relebactam and Vaborbactam in Combination with β-Lactams against Mycobacterium abscessus Complex Clinical Isolates. Antimicrob Agents Chemother. 2019;63(3):e02623-18. doi: 10.1128/ AAC.02623-18</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Mukherjee D, Wu ML, Teo JWP, Dick T. Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro. Antimicrob Agents Chemother. 2017;61(12):e01298-17. doi: 10.1128/AAC.01298-17</mixed-citation><mixed-citation xml:lang="en">Mukherjee D, Wu ML, Teo JWP, Dick T. Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro. Antimicrob Agents Chemother. 2017;61(12):e01298-17. doi: 10.1128/AAC.01298-17</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Story-Roller E, Maggioncalda EC, Lamichhane G. Select β-Lactam Combinations Exhibit Synergy against Mycobacterium abscessus In Vitro. Antimicrob Agents Chemother. 2019;63(4):e02613-18. doi: 10.1128/AAC.02613-18</mixed-citation><mixed-citation xml:lang="en">Story-Roller E, Maggioncalda EC, Lamichhane G. Select β-Lactam Combinations Exhibit Synergy against Mycobacterium abscessus In Vitro. Antimicrob Agents Chemother. 2019;63(4):e02613-18. doi: 10.1128/AAC.02613-18</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Dedrick RM, Guerrero-Bustamante CA, Garlena RA, et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med. 2019;25(5):730-733. doi: 10.1038/s41591-019-0437-z</mixed-citation><mixed-citation xml:lang="en">Dedrick RM, Guerrero-Bustamante CA, Garlena RA, et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med. 2019;25(5):730-733. doi: 10.1038/s41591-019-0437-z</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
